Felicitex Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • IPO
  • (Postponed)

  • Financing Rounds
  • 3

Felicitex Therapeutics General Information

Description

Operator of a drug discovery platform dedicated to developing novel treatments for dormant cancers. The company offers treatments for therapy-resistant liquid and solid tumors such as hematopoietic, ovarian, pancreatic, colorectal, osteosarcoma, glioblastoma and lungs, thereby helping patients kill cancer cells and eliminate its ability to enter dormancy and develop resistant phenotype.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 27 Strathmore Road
  • Natick, MA 01760
  • United States
+1 (919) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Felicitex Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Felicitex Therapeutics‘s full profile, request access.

Request a free trial

Felicitex Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug discovery platform dedicated to developing novel treatments for dormant cancers. The company offers t
Drug Discovery
Natick, MA
3 As of 2024
000.00 0000-00-00
00000000

000000

a aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nis
0000 000000000
New York, NY
00 As of 0000
00000
00000 0000-00-00
00000000000 00000

0000 0

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
0000000000000
Santa Monica, CA
0000 As of 0000
00000
000.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Felicitex Therapeutics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HiberCell Venture Capital-Backed New York, NY 00 00000 00000000000 00000
Kite Pharma Formerly VC-backed Santa Monica, CA 0000 00000 000000&0 00000
Volastra Venture Capital-Backed New York, NY 00 00000 0000000000 0 00000
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
Biosplice Therapeutics Private Equity-Backed San Diego, CA 000 00000 00000000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

Felicitex Therapeutics Patents

Felicitex Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4183786-A1 Derivatives of quinolines as inhibitors of dyrk1a and/or dyrk1b kinases Pending 23-Dec-2016 0000000000 00
JP-2022166286-A Derivatives of quinolines as inhibitors of dyrk1a and/or dyrk1b kinases Pending 23-Dec-2016 0000000000 0
US-20180179199-A1 Derivatives of quinoline as inhibitors of dyrk1a and/or dyrk1b kinases Active 23-Dec-2016 0000000000 0
US-10577365-B2 Derivatives of quinoline as inhibitors of dyrk1a and/or dyrk1b kinases Active 23-Dec-2016 0000000000 0
EP-3558321-B1 Derivatives of quinolines as inhibitors of dyrk1a and/or dyrk1b kinases Active 23-Dec-2016 C07D471/04
To view Felicitex Therapeutics’s complete patent history, request access »

Felicitex Therapeutics Executive Team (3)

Name Title Board Seat
Maria Vilenchik Ph.D Co-Founder, Chief Executive Officer and Director
Yuriy Gankin Ph.D Co-Founder, Scientific Advisory and Board of Directors
Michael Frid Ph.D Co-Founder & Vice Presdient
To view Felicitex Therapeutics’s complete executive team members history, request access »

Felicitex Therapeutics Board Members (5)

Name Representing Role Since
0000 000000000000 Self Board Member & Scientific Advisor 000 0000
0000 0000 Duce Management Chairman 000 0000
0000 00000 00.0 Self Board Member & Scientific Advisor 000 0000
0000000 0000000000 Self Board Member & Scientific Advisor 000 0000
00000 000000 00.0 Self Co-Founder, Scientific Advisory and Board of Directors 000 0000
To view Felicitex Therapeutics’s complete board members history, request access »

Felicitex Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Felicitex Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Felicitex Therapeutics‘s full profile, request access.

Request a free trial

Felicitex Therapeutics FAQs

  • When was Felicitex Therapeutics founded?

    Felicitex Therapeutics was founded in 2012.

  • Who is the founder of Felicitex Therapeutics?

    Maria Vilenchik Ph.D, Yuriy Gankin Ph.D, and Michael Frid Ph.D are the founders of Felicitex Therapeutics.

  • Who is the CEO of Felicitex Therapeutics?

    Maria Vilenchik Ph.D is the CEO of Felicitex Therapeutics.

  • Where is Felicitex Therapeutics headquartered?

    Felicitex Therapeutics is headquartered in Natick, MA.

  • What is the size of Felicitex Therapeutics?

    Felicitex Therapeutics has 3 total employees.

  • What industry is Felicitex Therapeutics in?

    Felicitex Therapeutics’s primary industry is Drug Discovery.

  • Is Felicitex Therapeutics a private or public company?

    Felicitex Therapeutics is a Private company.

  • What is the current valuation of Felicitex Therapeutics?

    The current valuation of Felicitex Therapeutics is 000.00.

  • What is Felicitex Therapeutics’s current revenue?

    The current revenue for Felicitex Therapeutics is 000000.

  • Who are Felicitex Therapeutics’s investors?

    Duce Management and Massachusetts Life Sciences Center have invested in Felicitex Therapeutics.

  • Who are Felicitex Therapeutics’s competitors?

    HiberCell, Kite Pharma, Volastra, Inovio Pharmaceuticals, and Biosplice Therapeutics are some of the 9 competitors of Felicitex Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »